Side Effects of Valproic Acid, Causes of Alopecia and Obesity
Keywords:
Valproic acid, alopecia, obesity, antiepileptic drug, mitochondrial toxicity, metabolic pathwaysAbstract
Valproic acid (VPA) is a widely used antiepileptic drug that has proven effective in controlling seizures and mood disorders. However, its use is often associated with a range of side effects, including alopecia (hair loss) and obesity, which can significantly impact the quality of life of patients. This research article explores the underlying mechanisms and causes of these side effects, focusing on recent findings in clinical and molecular studies. Understanding the causes of alopecia and obesity in patients treated with valproic acid is crucial for developing targeted strategies to mitigate these adverse effects.
References
Biton, V., Mirza, W., Montouris, G. D., Vuong, A., Hammer, A. E., & Barrett, P. S. (2003). Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology, 60(9), 1260-1262.
Coppola, G., D’Aniello, A., Pascotto, A., & Moshé, S. L. (2001). Valproate-induced hair loss is associated with low serum biotin levels. Epilepsia, 42(2), 287-291.
Emadi-Konjin, P., Dehpour, A. R., & Anvari, M. (2005). Selenium and biotin levels in epileptic patients treated with sodium valproate. Clinical Neurology and Neurosurgery, 107(5), 310-314.
Isojärvi, J. I., Räkköläinen, V., Myllylä, V. V., Pakarinen, A. J., Laatikainen, T. J., & Juntunen, K. T. (2001). Thyroid function with valproate, carbamazepine, and oxcarbazepine. Epilepsia, 42(8), 930-934.
Isojärvi, J. I., Laatikainen, T. J., Knip, M., Pakarinen, A. J., Juntunen, K. T., & Myllylä, V. V. (1998). Obesity and endocrine disorders in women taking valproate for epilepsy. Annals of Neurology, 43(5), 579-584.
Mula, M., Pini, S., & Cassano, G. B. (2012). Screening for overweight/obesity and eating patterns in patients with epilepsy. Epilepsia, 53(3), 482-488.
Lim, S. H., & Ahn, J. S. (2004). Mechanisms of valproate-associated weight gain and obesity: Is insulin resistance the culprit? CNS Drugs, 18(3), 183-195.
Nanau, R. M., & Neuman, M. G. (2013). Adverse drug reactions induced by valproic acid. Clinical Biochemistry, 46(15), 1323-1338.
Perucca, E. (2002). Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience. CNS Drugs, 16(10), 695-714.
Z Abdurakhmanova. M Eshkabilova Creation of Selective Sensors and Alarms for Monitoring Carbon Dioxide and Methane World Journal of Agriculture and Urbanization 9-13 Amerika
Dr. Imran Aslam, Ph.D.,Dr Ayesha Ashraf.,Abdurakhmanova Zamira (2024).,Demographic and Clinical Profile Of Chronic Myeloid Leukemia Patients in a Resource-Limited Setting: A Comprehensive Analysis PD.,International Journal of Integrative and Modern Medicine 2 (ISSN: 2995-5319) 128-134
Abdurakhmanov Ergashboy , Eshkobilova Mavjuda., Zol-gel synthesis of nanocomposites and gaseous materials., The International Conference on “Energy-Earth-Environment-Engineering”4 (4) 5 December 2023 Tashkent, Uzbekistan 84-85
